MoonLake Immunotherapeutics (MLTX)
MLTX Stock Price Chart
Explore MoonLake Immunotherapeutics interactive price chart. Choose custom timeframes to analyze MLTX price movements and trends.
MLTX Company Profile
Discover essential business fundamentals and corporate details for MoonLake Immunotherapeutics (MLTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Oct 2020
Employees
100.00
Website
https://www.moonlaketx.comCEO
Jorge Santos da Silva
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
MLTX Financial Timeline
Browse a chronological timeline of MoonLake Immunotherapeutics corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.88.
Earnings released on 5 Aug 2025
EPS came in at -$0.87 falling short of the estimated -$0.73 by -19.18%.
Earnings released on 12 May 2025
EPS came in at -$0.63 surpassing the estimated -$0.76 by +17.11%.
Earnings released on 26 Feb 2025
EPS came in at -$0.72 falling short of the estimated -$0.53 by -35.85%, while revenue for the quarter reached $101.85K .
Earnings released on 7 Nov 2024
EPS came in at -$0.56 falling short of the estimated -$0.44 by -27.27%.
Earnings released on 7 Aug 2024
EPS came in at -$0.39 falling short of the estimated -$0.28 by -39.29%.
Earnings released on 7 May 2024
EPS came in at -$0.22 falling short of the estimated -$0.21 by -4.76%.
Earnings released on 29 Feb 2024
EPS came in at -$0.12 surpassing the estimated -$0.21 by +42.86%, while revenue for the quarter reached $19.74K .
Earnings released on 14 Nov 2023
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%.
Earnings released on 10 Aug 2023
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%.
Earnings released on 12 May 2023
EPS came in at -$0.23 surpassing the estimated -$0.28 by +17.86%.
Earnings released on 20 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.32 by +3.13%.
Earnings released on 14 Nov 2022
EPS came in at -$0.27 surpassing the estimated -$0.32 by +15.62%.
Earnings released on 12 Aug 2022
EPS came in at -$0.34 surpassing the estimated -$0.54 by +37.04%.
Earnings released on 16 May 2022
EPS came in at -$0.43 .
Earnings released on 17 Feb 2022
EPS came in at -$0.15 .
Earnings released on 12 Nov 2021
EPS came in at -$0.17 .
Earnings released on 16 Aug 2021
EPS came in at -$0.89 .
Earnings released on 21 May 2021
EPS came in at -$0.01 .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 .
MLTX Stock Performance
Access detailed MLTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.